MELGEN at the European Researchers’ Night 2018!

European Researchers’ Night is an annual open science initiative that occurs in September which is dedicated to bringing popular science and the work of scientists into the general public. Over the course of two days, there are several events that are organized across Europe which help to interact andRead More

Can we slow down skin cancer progression?

The progression from benign cells to melanoma is not fully understood. In addition to genetic alterations, some epigenetic mechanisms, the ones that do not involve DNA sequence, play a role in the development and evolution of melanoma. My PhD project aims to disclose the epigenetic features behind melanoma progression. WeRead More

15th Annual Joint GenoMEL/BioGenoMEL/MELGEN Scientific Meeting 2018

From the 20th to the 22nd March 2018 the MELGEN Consortium joined forces with the GenoMEL and BioGenoMEL consortia to hold their annual scientific meeting, this year hosted by the University Hospital Essen in Germany. In contrast to last year’s sun and high temperatures, the start of this year’sRead More

A Native Scientist workshop: How I explained skin cancer to kids

To explain my research to school pupils, I aimed at simplifying the notion of ‘cancer’, how it can invade and metastasize. I focused on skin cancer and to better illustrate it, I built a set of three interactive schemes mimicking the different skin cell types and how they canRead More

MELGEN training in Leeds – version 2.0

As part of the Marie Skłodowska-Curie Early Training Network, MELGEN fellows participate in seminars and workshops which boost up their scientific skills! Last May, we attended intense training activities at the gorgeous city of Camogli in Italy. MELGEN training was carried out in July in our coordinating place, Leeds,Read More

14th Annual Joint GenoMEL/BioGenoMEL/MELGEN Scientific Meeting 2017

From the 15th to the 17th May 2017, the MELGEN researchers, together with their group leaders, will be gathering in Camogli, Italy to attend the 14th annual scientific meeting of the GenoMEL, BioGenoMEL and MELGEN consortia. Founded in 1997, the GenoMEL consortium was formed by a number of melanomaRead More

Cancer epigenetic research as a bridge between academia–industry partnerships

Cancer epigenetics is an area of ongoing research that deepens our understanding of the molecular pathogenesis of cancer and creates new avenues for the identification of novel therapeutic targets. The term “epigenetics” was originally proposed by Conrad Waddington in 1942 to describe the molecular mechanisms independent of alterations inRead More

Leeds University welcomes ESRs

This year annual GenoMEL scientific meeting was held in Leeds, UK in April and 17 MELGEN Early Stage Researchers (ESRs) who are spread across Europe joined 60 other delegates to find out about the latest melanoma research. During the meeting PhD students presented their projects and preliminary data duringRead More

MELGEN Complementary Training Course 14th-19th April 2016

From the 14-19th April 2016, all the MELGEN Early Stage Researchers will take part in a series of Complementary Skills training courses designed to develop their abilites in a number of key areas such as: developing their effectiveness as a researcher presenting to scientific and general audiences both orallyRead More